EI

251.2

-0.83%↓

SAN

81.4

+0.28%↑

SHL.DE

45.79

-0.93%↓

ARGX

548.8

-1.72%↓

PHIA

23.14

+0.74%↑

EI

251.2

-0.83%↓

SAN

81.4

+0.28%↑

SHL.DE

45.79

-0.93%↓

ARGX

548.8

-1.72%↓

PHIA

23.14

+0.74%↑

EI

251.2

-0.83%↓

SAN

81.4

+0.28%↑

SHL.DE

45.79

-0.93%↓

ARGX

548.8

-1.72%↓

PHIA

23.14

+0.74%↑

EI

251.2

-0.83%↓

SAN

81.4

+0.28%↑

SHL.DE

45.79

-0.93%↓

ARGX

548.8

-1.72%↓

PHIA

23.14

+0.74%↑

EI

251.2

-0.83%↓

SAN

81.4

+0.28%↑

SHL.DE

45.79

-0.93%↓

ARGX

548.8

-1.72%↓

PHIA

23.14

+0.74%↑

Search

Carl Zeiss Meditec AG

Open

SectorHealthcare

42.22 -1.08

Overview

Share price change

24h

Current

Min

41.5

Max

42.96

Key metrics

By Trading Economics

Income

30M

45M

Sales

70M

560M

P/E

Sector Avg

26.136

34.393

EPS

0.52

Dividend yield

1.3

Profit margin

8.095

Employees

5,713

EBITDA

35M

72M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+31.92% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.30%

2.54%

Market Stats

By TradingEconomics

Market Cap

-1.4B

4B

Previous open

43.3

Previous close

42.22

News Sentiment

By Acuity

38%

62%

121 / 374 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

Carl Zeiss Meditec AG Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

8 kwi 2025, 08:20 UTC

Market Talk

Med-Tech Investors Seek 'Safe Havens' Amid Tariff Fears -- Market Talk

28 paź 2024, 11:15 UTC

Market Talk
Earnings

Med-Tech Stocks Drop Amid Subdued Demand in China -- Market Talk

Peer Comparison

Price change

Carl Zeiss Meditec AG Forecast

Price Target

By TipRanks

31.92% upside

12 Months Forecast

Average 56.78 EUR  31.92%

High 72 EUR

Low 35.1 EUR

Based on 12 Wall Street analysts offering 12 month price targets forCarl Zeiss Meditec AG - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

12 ratings

3

Buy

8

Hold

1

Sell

Technical Score

By Trading Central

58.75 / 60.35Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Weak Bearish Evidence

Sentiment

By Acuity

121 / 374 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.